Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis

Summary

This randomized controlled, multi-center study will carry out to assess the efficacy of GB-0998 compared to plasmapheresis in the treatment of the generalized Myasthenia Gravis based on the changes in Quantitative Myasthenia Gravis score (QMG score) as primary endpoint, and in addition, to assess the safety of GB-0998

Timeline

Start

2007-07

Primary completion

2010-05

Completion

2010-06

Drugs

Indications